🇺🇸 FDA
Patent

US 11229609

Compositions and methods for organ specific delivery of nucleic acids

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 11229609 (Compositions and methods for organ specific delivery of nucleic acids) held by The Board of Regents of the University of Texas System expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K31/7105, A61K31/713, A61K47/6907, A61K47/6929